{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T21:37:23Z","timestamp":1766612243772,"version":"3.44.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ahj.2023.03.003","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T03:11:59Z","timestamp":1679022719000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Effect of active vitamin-D on left ventricular mass index: Results of a randomized controlled trial in type 2 diabetes and chronic kidney disease"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6353-630X","authenticated-orcid":false,"given":"Luigi","family":"Gnudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Fountoulakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki","family":"Panagiotou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Corcillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Maltese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Flaquer","family":"Rife","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Ntalas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Franks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amedeo","family":"Chiribiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Ayis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaka","family":"Karalliedde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.03.003_bib0001","first-page":"88","article-title":"The unrecognized prevalence of chronic kidney disease in diabetes","volume":"21","author":"Middleton","year":"2006","journal-title":"NephrolDialTransplant"},{"key":"10.1016\/j.ahj.2023.03.003_bib0002","first-page":"364","article-title":"Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice","volume":"24","author":"New","year":"2007","journal-title":"DiabetMed"},{"key":"10.1016\/j.ahj.2023.03.003_bib0003","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"NEnglJ Med"},{"key":"10.1016\/j.ahj.2023.03.003_bib0004","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2023.03.003_bib0005","first-page":"2768","article-title":"Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis","volume":"12","author":"Zoccali","year":"2001","journal-title":"J AmSocNephrol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0006","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/sj.ki.5001605","article-title":"Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis","volume":"70","author":"Wang","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2023.03.003_bib0007","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/hr.2012.40","article-title":"The ratio of observed to predicted left ventricular mass is independently associated with increased cardiovascular events in patients with chronic kidney disease","volume":"35","author":"Chen","year":"2012","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ahj.2023.03.003_bib0008","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1681\/ASN.2009060631","article-title":"Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD","volume":"20","author":"Eckardt","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9149(91)90716-X","article-title":"Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study)","volume":"68","author":"Galderisi","year":"1991","journal-title":"AmJ Cardiol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diacare.24.1.5","article-title":"Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy","volume":"24","author":"Poirier","year":"2001","journal-title":"Diabetes care"},{"key":"10.1016\/j.ahj.2023.03.003_bib0011","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000435838","article-title":"Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment","volume":"5","author":"Di Lullo","year":"2015","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.ahj.2023.03.003_bib0012","first-page":"1442","article-title":"Active vitamin D and survival","volume":"19","author":"Wolf","year":"2008","journal-title":"J AmSocNephrol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0013","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1523-1755.2005.00651.x","article-title":"Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?","volume":"68","author":"Levin","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2023.03.003_bib0014","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2023.03.003_bib0015","first-page":"397","article-title":"Association of activated vitamin D treatment and mortality in chronic kidney disease","volume":"168","author":"Kovesdy","year":"2008","journal-title":"ArchInternMed"},{"key":"10.1016\/j.ahj.2023.03.003_bib0016","first-page":"1613","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J AmSocNephrol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0017","first-page":"229","article-title":"Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J ClinInvest"},{"key":"10.1016\/j.ahj.2023.03.003_bib0018","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ki.2008.101","article-title":"Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice","volume":"74","author":"Zhou","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2023.03.003_bib0019","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems","volume":"288","author":"Xiang","year":"2005","journal-title":"AmJ Physiol EndocrinolMetab"},{"key":"10.1016\/j.ahj.2023.03.003_bib0020","first-page":"S29","article-title":"The importance of the renin-angiotensin system in reversal of left ventricular hypertrophy","volume":"11","author":"Dahlof","year":"1993","journal-title":"J HypertensSuppl"},{"key":"10.1016\/j.ahj.2023.03.003_bib0021","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2337\/dc08-0371","article-title":"Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)","volume":"31","author":"Ruggenenti","year":"2008","journal-title":"Diabetes care"},{"key":"10.1016\/j.ahj.2023.03.003_bib0022","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.118.11065","article-title":"Role of Renin-angiotensin-aldosterone system activation in promoting cardiovascular fibrosis and stiffness","volume":"72","author":"Jia","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2023.03.003_bib0023","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.03.003_bib0024","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0272-6386(99)70260-X","article-title":"Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism","volume":"33","author":"Park","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2023.03.003_bib0025","doi-asserted-by":"crossref","first-page":"c21","DOI":"10.1159\/000088295","article-title":"Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis","volume":"102","author":"Kim","year":"2006","journal-title":"Nephron ClinPract"},{"key":"10.1016\/j.ahj.2023.03.003_bib0026","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"Jama"},{"key":"10.1016\/j.ahj.2023.03.003_bib0027","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/ehjcvp\/pvz080","article-title":"Impact of vitamin D on cardiac structure and function in chronic kidney disease patients with hypovitaminosis D: a randomized controlled trial and meta-analysis","volume":"7","author":"Banerjee","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.ahj.2023.03.003_bib0028","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/00365599.2012.693131","article-title":"Effect of alfacalcidol on cardiac function in patients with chronic kidney disease stage 4 and secondary hyperparathyroidism: a pilot study","volume":"46","author":"Ivarsen","year":"2012","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0029","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/HYPERTENSIONAHA.113.02177","article-title":"Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial","volume":"63","author":"Witham","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2023.03.003_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD\u2013the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0031","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/hy0302.104674","article-title":"Assessment of left ventricular mass by cardiovascular magnetic resonance","volume":"39","author":"Myerson","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2023.03.003_bib0032","first-page":"343","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. 1949","volume":"6","author":"Sokolow","year":"2001","journal-title":"AnnNoninvasiveElectrocardiol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0033","first-page":"577","article-title":"Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)dagger","volume":"16","author":"Marwick","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2023.03.003_bib0034","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1532-429X-11-18","article-title":"Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance","volume":"11","author":"Buchner","year":"2009","journal-title":"J CardiovascMagn Reson"},{"key":"10.1016\/j.ahj.2023.03.003_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","article-title":"Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on standardized post-processing","volume":"22","author":"Schulz-Menger","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.ahj.2023.03.003_bib0036","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/HYPERTENSIONAHA.108.111674","article-title":"Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering","volume":"51","author":"Karalliedde","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2023.03.003_bib0037","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.clinbiochem.2017.09.006","article-title":"Analytical verification and method comparison of the ADVIA Centaur(R) Intact Parathyroid Hormone assay","volume":"50","author":"Fernandez-Galan","year":"2017","journal-title":"Clin Biochem"},{"issue":"8","key":"10.1016\/j.ahj.2023.03.003_bib0038","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1301\/nr.2007.aug.S87-S90","article-title":"Assessment of circulating 25(OH)D and 1,25(OH)2D: emergence as clinically important diagnostic tools","volume":"65","author":"Hollis","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.ahj.2023.03.003_bib0039","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1681\/ASN.2010010063","article-title":"Comparison of different measures of urinary protein excretion for prediction of renal events","volume":"21","author":"Lambers Heerspink","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1359\/jbmr.090717","article-title":"Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients","volume":"25","author":"Testa","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ahj.2023.03.003_bib0041","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.CIR.103.2.226","article-title":"Left ventricular hypertrophy with exercise and ACE gene insertion\/deletion polymorphism: a randomized controlled trial with losartan","volume":"103","author":"Myerson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.03.003_bib0042","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00005344-199811000-00012","article-title":"Benazepril causes in hypertension a greater reduction in left ventricular mass than does nitrendipine: a randomized study using magnetic resonance imaging","volume":"32","author":"Gaudio","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0043","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0735-1097(96)00451-2","article-title":"Angiotensin-converting enzyme inhibitor therapy affects left ventricular mass in patients with ejection fraction >40% after acute myocardial infarction","volume":"29","author":"Johnson","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0044","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.jacc.2013.07.074","article-title":"Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy","volume":"62","author":"Szwejkowski","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2023.03.003_bib0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jacc.2009.03.066","article-title":"Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial","volume":"54","author":"Edwards","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0046","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2215\/CJN.01930221","article-title":"Effects of Spironolactone and Chlorthalidone on cardiovascular structure and function in chronic kidney disease: a randomized, open-label trial","volume":"16","author":"Edwards","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2023.03.003_bib0047","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/ehjci\/jeaa089","article-title":"Variation in left ventricular cardiac magnetic resonance normal reference ranges: systematic review and meta-analysis","volume":"22","author":"Raisi-Estabragh","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2023.03.003_bib0048","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.HYP.35.2.580","article-title":"Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension","volume":"35","author":"Schillaci","year":"2000","journal-title":"Hypertension"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:09:20Z","timestamp":1757570960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":48,"alternative-id":["S0002870323000625"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.03.003","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of active vitamin-D on left ventricular mass index: Results of a randomized controlled trial in type 2 diabetes and chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}